References
- Bosch C., Muhaisen A., Pujadas L., Soriano E., Martínez A.: Reelin Exerts Structural, Biochemical and Transcriptional Regulation Over Presynaptic and Postsynaptic Elements in the Adult Hippocampus. Frontiers in Cellular Neuroscience, 2016, 10: 138.
- Camfield P., Camfield C.: Incidence, prevalence and etiology of seizures and epilepsy in children. Epileptic Disord., 2015, 17: 117–123.
- Cárdenas-Rodríguez N., Carmona-Aparicio L., Pérez-Lozano D.L., Ortega-Cuellar D., Gómez-Manzo S., Ignacio-Mejía I.: Genetic variations associated with pharmacoresistant epilepsy. Mol. Med. Rep., 2020, 21: 1685–1701.
- Choi H., Hayat M.J., Zhang R., Hirsch L.J., Bazil C.W., Mendiratta A. et al.: Drug resistant epilepsy in adults: Outcome trajectories after failure of two medications. Epilepsia, 2016, 57: 1152–1160.
- Depondt C.: The potential of pharmacogenetics in the treatment of epilepsy. Eur. J. Paediatr. Neurol., 2006, 10: 57–65.
- Dutta S., Gangopadhyay P.K., Sinha S., Chatterjee A., Ghosh S., Rajamma U.: An association analysis of reelin gene (RELN) polymorphisms with childhood epilepsy in eastern Indian population from West Bengal. Cell Mol. Neurobiol., 2011, 31: 45–56.
- Fiest K.M., Sauro K.M., Wiebe S., Patten S.B., Kwon C.-S., Dykeman J. et al.: Prevalence and incidence of epilepsy. Neurology, 2017, 88: 296–303.
- Kalilani L., Sun X., Pelgrims B., Noack-Rink M., Villanueva V.: The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis. Epilepsia, 2018. https://doi.org/10.1111/epi.14596
- Hong S.E., Shugart Y.Y., Huang D.T., Shahwan S.A., Grant P.E., Hourihane J.O. et al.: Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat. Genet., 2000, 26: 93–96.
- Kang, S.K., Vanoye C.G., Misra S.N., Echevarria D.M., Calhoun J.D., O’Connor J.B. et al.: High throughput Characterization of KCNB1 variants Associated with Developmental and Epileptic Encephalopathy. Bio Rxiv., 2019, 86: 899–912.
- Kovel, C.G.F de, Syrbe S., Brilstra E.H., Verbeek N., Kerr B., Dubbs H. et al.: Neurodevelopmental Disorders Caused by de Novo Variants in KCNB1 Genotypes and Phenotypes. JAMA Neurol., 2017, 74: 1228–1236.
- Kwan P., Brodie M.J.: Early identification of refractory epilepsy. N. Engl. J. Med., 2000, 342: 314–319.
- Kwan P., Arzimanoglou A., Berg A.T., Brodie M.J., Allen Hauser W., Mathern G. et al.: Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia, 2010, 51: 1069–1077.
- López González F.J., Rodríguez Osorio X., Gil-Nagel Rein A., Carreño Martínez M., Serratosa Fernández J., Villanueva Haba V. et al.: Drug-resistant epilepsy: Definition and treatment alternatives. Neurologia, 2015, 30: 439–446. (In English, Spanish).
- Luciano A.L., Shorvon S.D.: Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann. Neurol., 2007, 62: 375–381.
- Marini, C., Romoli M., Parrini E., Costa C., Mei D., Mari F. et al.: Clinical features and outcome of 6 new patients carrying de novo KCNB1 gene mutations. Neurol. Genet., 2017, 3: e206.
- Michelucci R., Pulitano P., Di Bonaventura C., Binelli S., Luisi C., Pasini E. et al.: The clinical phenotype of autosomal dominant lateral temporal lobe epilepsy related to reelin mutations. Epilepsy Behav., 2017, 68: 103–107.
- Myers C.T., Mefford H.C.: Advancing epilepsy genetics in the genomic era. Genome Med., 2015, 7: 91.
- Sun Y., Seneviratne U., Perucca P., Chen Z., Tan M.K., O’Brien T.J. et al.: Generalized polyspike train: An EEG biomarker of drug-resistant idiopathic generalized epilepsy. Neurology, 2018, 91: e1822–e1830.
- Szaflarski J.P., Lindsell C.J., Zakaria T., Banks C., Privitera M.D.: Seizure control in patients with idiopathic generalized epilepsies: EEG determinants of medication response. Epilepsy Behav., 2010, 17: 525–530.
- Téllez-Zenteno J.F., Hernández-Ronquillo L., Buckley S., Zahagun R., Rizvi S.: A validation of the new definition of drug-resistant epilepsy by the International League Against Epilepsy. Epilepsia, 2014, 55: 829–834.
- Torkamani, A., Bersell K., Jorge B.S., Bjork R.L. Jr, Friedman J.R., Bloss C.S. et al.: De novo KCNB1 mutations in epileptic encephalopathy. Ann. Neurol., 2014, 76: 529–540.